Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation

Atrial fibrillation (AF) is the most common cardiac cause of systemic embolism and cardioembolic stroke. The risk of thromboembolic complications increases significantly when performing for electrical cardioversion. Vitamin K antagonists (warfarin) more often used to prepare for electrical cardiover...

Full description

Bibliographic Details
Main Authors: N. A. Novikova, A. N. Volovchenko
Format: Article
Language:English
Published: Столичная издательская компания 2016-11-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
atrial fibrillation
electrical cardioversion
warfarin
dabigatran
Online Access:https://www.rpcardio.online/jour/article/view/1341

Similar Items

Similar Items